Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/17251
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis
Author: Dodd, J.
Crowther, C.
Cincotta, R.
Flenady, V.
Robinson, J.
Citation: Acta Obstetricia et Gynecologica Scandinavica, 2005; 84(6):526-533
Publisher: Munksgaard Int Publ Ltd
Issue Date: 2005
ISSN: 0001-6349
1600-0412
Statement of
Responsibility: 
Jodie M. Dodd, Caroline A. Crowther, Robert Cincotta, Vicki Flenady, Jeffrey S. Robinson
Abstract: AIM: The aim of this study is to assess the role of progesterone in preterm birth prevention. METHODS: A MEDLINE search (from 1966 to the present; date of last search January 2005) was performed - using the key words progesterone, pregnancy, preterm birth, preterm labor, and randomized, controlled trial - in order to identify randomized, controlled trials in which progesterone (either intramuscular or vaginal administration) was compared with placebo or no treatment. Data were extracted and a meta-analysis was performed. RESULTS: Seven randomized, controlled trials were identified. Women who received progesterone were statistically significantly less likely to give birth before 37 weeks (seven studies, 1020 women, RR = 0.58, 95% CI = 0.48-0.70), to have an infant with birth weight of < or =2.5 kg (six studies, 872 infants, RR = 0.62, 95% CI = 0.49-0.78), or to have an infant diagnosed with intraventricular hemorrhage (one study, 458 infants, RR = 0.25, 95% CI = 0.08-0.82). CONCLUSIONS: For progesterone supplementation to be advocated for women at the risk of preterm birth, the prolongation of gestation demonstrated in this meta-analysis must translate into improved infant outcomes, including a reduction in mortality. There is currently insufficient information to allow recommendations regarding the optimal dose, route, and timing of administration of progesterone supplementation.
Keywords: Humans; Birth Weight; Progesterone; Tocolytic Agents; Administration, Intravaginal; Gestational Age; Pregnancy; Infant, Newborn; Female; Obstetric Labor, Premature; Randomized Controlled Trials as Topic
Description: The definitive version is available at www.blackwell-synergy.com
RMID: 0020050374
DOI: 10.1111/j.0001-6349.2005.00835.x
Published version: http://www.blackwell-synergy.com/doi/abs/10.1111/j.0001-6349.2005.00835.x
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.